JNJ

223.91

-0.78%↓

UNH

368.21

+1.25%↑

TMO

473.42

+1.38%↑

ISRG

450

-0.12%↓

DHR

174.6

-0.58%↓

JNJ

223.91

-0.78%↓

UNH

368.21

+1.25%↑

TMO

473.42

+1.38%↑

ISRG

450

-0.12%↓

DHR

174.6

-0.58%↓

JNJ

223.91

-0.78%↓

UNH

368.21

+1.25%↑

TMO

473.42

+1.38%↑

ISRG

450

-0.12%↓

DHR

174.6

-0.58%↓

JNJ

223.91

-0.78%↓

UNH

368.21

+1.25%↑

TMO

473.42

+1.38%↑

ISRG

450

-0.12%↓

DHR

174.6

-0.58%↓

JNJ

223.91

-0.78%↓

UNH

368.21

+1.25%↑

TMO

473.42

+1.38%↑

ISRG

450

-0.12%↓

DHR

174.6

-0.58%↓

Search

Abbott Laboratories

Aperta

SettoreSettore sanitario

86.95 -0.39

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

86.31

Massimo

87.81

Metriche Chiave

By Trading Economics

Entrata

132M

1.8B

Vendite

-295M

11B

P/E

Media del settore

25.994

67.147

EPS

1.15

Rendimento da dividendi

2.68

Margine di Profitto

15.499

Dipendenti

122,000

EBITDA

-980M

1.8B

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+37.35% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

2.68%

2.36%

Utili prossimi

16 lug 2026

Prossima data del Dividendo

15 mag 2026

Prossima data del' Ex Dividendo

14 lug 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-14B

161B

Apertura precedente

87.34

Chiusura precedente

86.95

Notizie sul Sentiment di mercato

By Acuity

24%

76%

85 / 347 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Weak Bullish Evidence

Abbott Laboratories Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

16 apr 2026, 15:13 UTC

Utili
I principali Market Mover

Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt 1Q Sales -- Update

16 apr 2026, 12:23 UTC

Utili
I principali Market Mover

Abbott Laboratories Cuts Outlook, Narrows 1Q Profit

22 gen 2026, 18:36 UTC

Utili
I principali Market Mover

Abbott Laboratories Raised Prices, Prompting Sales Slump -- Update

22 gen 2026, 13:23 UTC

Utili
I principali Market Mover

Abbott Laboratories 4Q Sales Grow, Outlook Underwhelms

16 apr 2026, 20:23 UTC

Utili

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

16 apr 2026, 16:15 UTC

Utili

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

16 apr 2026, 14:00 UTC

Discorsi di Mercato
Utili

A Mild Flu Season Hurt Abbott's Recent Quarter -- Market Talk

16 apr 2026, 13:59 UTC

Discorsi di Mercato
Utili

Abbott Laboratories Has Disappointing Quarter -- Market Talk

16 apr 2026, 12:05 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Biting. -- Barrons.com

16 apr 2026, 11:32 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Abbott Labs: 2026 EPS View Includes 20c Dilution Related to Exact Sciences Buy >ABT

16 apr 2026, 11:30 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Abbott Labs Sees 2Q Adj EPS $1.25-Adj EPS $1.31 >ABT

16 apr 2026, 11:30 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Abbott Labs Sees 2026 Comparable Sales Growth of 6.5%-7.5% >ABT

16 apr 2026, 11:30 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Abbott Labs Updates Guidance to Reflect Acquisition of Exact Sciences >ABT

16 apr 2026, 11:30 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Abbott Labs 1Q Sales $11.16B >ABT

16 apr 2026, 11:30 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Abbott Reports First-Quarter 2026 Results; Updates Guidance To Reflect Acquisition Of Exact Sciences >ABT

16 apr 2026, 11:30 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Abbott Labs 1Q Net $1.08B >ABT

16 apr 2026, 11:30 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Abbott Labs 1Q Adj EPS $1.15 >ABT

16 apr 2026, 11:30 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Abbott Labs Sees FY Adj EPS $5.38-Adj EPS $5.58 >ABT

16 apr 2026, 11:30 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Abbott Labs 1Q EPS 61c >ABT

11 apr 2026, 00:00 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Big Yachts, Big Bucks -- Barrons.com

23 mar 2026, 12:50 UTC

Acquisizioni, Fusioni, Takeovers

Abbott Completes Acquisition Of Exact Sciences >ABT

20 mar 2026, 13:01 UTC

Acquisizioni, Fusioni, Takeovers

Abbott Labs: Received All Regulatory Clearances for Exact Sciences Buy >ABT EXAS

20 mar 2026, 13:00 UTC

Acquisizioni, Fusioni, Takeovers

Abbott Acquisition Of Exact Sciences Set To Close On March 23, 2026 >ABT

28 gen 2026, 14:48 UTC

Utili

Abbott Stock Fell the Most in 23 Years After Earnings. The CEO Bought $2 Million of Shares. -- Barrons.com

23 gen 2026, 16:59 UTC

Utili

Correction to Abbott Stock Drops Article on Jan. 22

22 gen 2026, 20:42 UTC

Utili

Abbott Stock Is on Pace for Worst Day Since 2000. The Nutrition Business Is a Drag on Earnings. -- Barrons.com

22 gen 2026, 16:19 UTC

Utili

Abbott Stock Slumps. The Nutrition Business Is a Drag on Earnings. -- Barrons.com

22 gen 2026, 15:22 UTC

Utili

Abbott Stock Drops on Slumping Sales of Baby Formula and Nutrition Shakes -- WSJ

22 gen 2026, 14:41 UTC

Azioni calde

Stocks to Watch Thursday: Intel, P&G, GE Aerospace -- WSJ

22 gen 2026, 14:08 UTC

Discorsi di Mercato
Utili

Abbott Posts Disappointing 4Q -- Market Talk

Confronto tra pari

Modifica del prezzo

Abbott Laboratories Previsione

Obiettivo di Prezzo

By TipRanks

37.35% in crescita

Previsioni per 12 mesi

Media 120.24 USD  37.35%

Alto 143 USD

Basso 92 USD

Basato su 20 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Abbott Laboratories - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

20 ratings

16

Acquista

4

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

132.82 / 134.43Supporto e resistenza

A breve termine

Weak Bullish Evidence

A termine intermedio

Neutral Evidence

A lungo termine

Bullish Evidence

Sentiment

By Acuity

85 / 347 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
help-icon Live chat